Bristol Myers Squibb
New cell therapy facility at Leiden Bio Science Park
American pharmaceutical company Bristol Myers Squibb (BMS) established a new cell therapy facility in the Oegstgeest part of the Leiden Bio Science Park.
Location
Information
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
The location close to Schiphol Airport is one of the main reasons BMS is located in LBSP Oegstgeest, an easy gateway to the rest of the world.
April 2024: The exterior of the imposing BMS building is now ready.
December 2023
October 2022
May 2022
Mei 2023
Jan 2022: De eerste contouren van BMS in een verder nog niet zo ver ontwikkeld Nieuw-Rhijngeest Zuid
January 2022: The fundaments of BMS in an otherwise not so developped Nieuw-Rhijngeest Zuid
Completed
-
2021-2024
Run time
-
Life, Science & Health
Type
-
Gemeente Leiden Universiteit Leiden
Landowner
-
19.000 m2
Surface area
- Credits Architect: KuiperCompagnons
- Roadworks Roadworks may affect traffic in the local area. For more information, please press the red button ‘All roadworks’.
